Investor Relations

Airdoc is a technology-driven innovation company centered on AI health foundation models. Guided by its mission of “making health accessible everywhere,” the company is committed to empowering individuals to better understand and manage their health through artificial intelligence.

Leveraging large-scale real-world health data, Airdoc has developed the “Wanyu” AI foundation model for personal health management. Powered by this model, Airdoc applies AI capabilities to chronic disease management scenarios, enabling the identification of dozens of retinal diseases and the early prediction of health risks such as myocardial infarction, stroke, and Alzheimer’s disease.

Building on this foundation, the company is accelerating the commercialization of the “Wanyu” model. On one hand, it integrates AI foundation models with photobiomodulation (PBM) technology to launch myopia prevention and control products. On the other hand, it has developed the Neuro-AI stress resilience monitoring and assessment application based on the “Wanyu” model, while continuously expanding into diversified chronic health management scenarios.